Prevest Denpro Ltd

₹ 393 1.95%
05 Dec 4:01 p.m.
About

Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.

Key Points

Product Portfolio
Company manufactures over 100 dental products which comprise of:
a) Clinical Products: Adhesives, Bonding Agents & Etchants, Auxiliaries, Cement and Liners, Composites, Endodontics, Finishing & Polishing, Impression Materials, Oral Care, Orthodontics, Retraction Materials, Temporaries, and Tooth Whitening. [1]
b) Laboratory Products: Acrylics, Auxiliaries, Base Plates & Waxes, and Gypsum Products. [2]

  • Market Cap 472 Cr.
  • Current Price 393
  • High / Low 494 / 267
  • Stock P/E 35.7
  • Book Value 53.4
  • Dividend Yield 0.00 %
  • ROCE 39.7 %
  • ROE 29.1 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.2%
  • Debtor days have improved from 35.2 to 22.5 days.

Cons

  • Stock is trading at 7.36 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2021 Mar 2022 Jun 2022 Sep 2022
11.12 9.33 12.30 11.21
6.52 6.42 7.79 7.00
Operating Profit 4.60 2.91 4.51 4.21
OPM % 41.37% 31.19% 36.67% 37.56%
0.67 0.86 0.68 0.82
Interest 0.02 -0.00 -0.00 -0.00
Depreciation 0.13 0.15 0.15 0.19
Profit before tax 5.12 3.62 5.04 4.84
Tax % 26.76% 32.04% 27.18% 31.20%
Net Profit 3.75 2.46 3.68 3.33
EPS in Rs 3.12 2.05 3.07 2.77
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
19 23 28 38 44
15 17 19 23 28
Operating Profit 4 5 9 15 16
OPM % 20% 23% 32% 39% 37%
0 2 1 2 3
Interest 0 0 0 0 0
Depreciation 0 0 0 1 1
Profit before tax 4 6 9 16 19
Tax % 20% 20% 23% 28%
Net Profit 3 5 7 12 13
EPS in Rs 1,049.12 1,757.89 252.98 9.64 11.01
Dividend Payout % -0% -0% -0% -0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 25%
TTM: 32%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 57%
TTM: 60%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 27%
Return on Equity
10 Years: %
5 Years: %
3 Years: 33%
Last Year: 29%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
0 0 0 12 12
Reserves 10 15 22 45 52
1 2 1 1 -0
4 4 7 6 6
Total Liabilities 15 21 31 64 70
5 5 5 7 7
CWIP -0 0 2 5 11
Investments 0 0 0 1 1
10 16 23 52 51
Total Assets 15 21 31 64 70

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022
3 5 9 7
-1 -1 -2 -4
0 0 -1 23
Net Cash Flow 2 4 6 26

Ratios

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 46 35 48 23
Inventory Days 28 59 59 122
Days Payable 70 72 181 61
Cash Conversion Cycle 4 22 -74 83
Working Capital Days 10 20 3 41
ROCE % 45% 47% 40%

Shareholding Pattern

Numbers in percentages

Sep 2021 Mar 2022 Jun 2022 Sep 2022
73.60 73.60 73.60 73.60
4.63 0.76 0.66 0.47
4.37 1.24 1.19 1.16
17.40 24.40 24.55 24.76

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents